Arbutus Biopharma Corporation earnings per share and revenue

ABUS earnings per share for the last quarter are -0.07 USD whereas the estimation was -0.08 USD which accounts for 9.68% surprise. Company revenue for the same period amounts to 1.57 M USD despite the estimated figure of 1.61 M USD. Estimated earnings per share for the next quarter are -0.11 USD, and revenue is expected to reach 1.82 M USD. Also watch annual changes over time to get a bigger picture of ABUS earnings per share and revenue dynamics.